DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia Syndrome
Simone Cesaro, Director of Pediatric Hematology Oncology at the Integrated University Hospital of Verona (AOUI), posted on LinkedIn:
”The study of methylation profile is a new way to approach the diagnosis and differential diagnosis of Blackfan-Diamond anemia.”
Read the full article here.
Title: DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia Syndrome
Authors: Paola Quarello, Karim Karimi, Slavica Trajkova, Emanuela Garelli, Mehdi Samadieh, Emanuela Iovino, Tommaso Pippucci, Giovanni Papagni, Sandra Dalfonso, Lucia Corrado, Serena Rizzo, Adriana Carando, Jennifer Kerkhof, Jessica Rzasa, Haley McConkey, Michael Levy, Marco Zecca, Francesca Fioredda, Angelica Barone, Simone Cesaro, Maria Gabelli, Francesca Torchio, Giulia Zucchetti, Maria Elena Cantarini, Paola Corti, Ugo Ramenghi, Franco Locatelli, Franca Fagioli, Bekim Sadikovic, Alfredo Brusco
Stay updated with Hemostasis Today.
-
Mar 7, 2026, 15:43Gevorg Tamamyan Joins The London Global Cancer Week Steering Group
-
Mar 7, 2026, 15:36Kenneth Monaghan: Empowering Stroke Survivors’ Self-Efficacy Through Neuroplasticity and Daily Activity
-
Mar 7, 2026, 15:31Tagreed Alkaltham: Practical Strategies for Navigating Blood Shortage Periods
-
Mar 7, 2026, 15:28Philip Wells Honored with the 2026 ISTH Esteemed Career Award
-
Mar 7, 2026, 15:27Gashaw Arega: A Challenging Case of Acute Immune Thrombocytopenia in an Adolescent
-
Mar 7, 2026, 15:25Worldwide Media Amplifies Call for Equity in Bleeding Disorders Care – WFH
-
Mar 7, 2026, 15:19Jecko Thachil: Can We Use Styptics as Topical Haemostats in Bleeding Disorders
-
Mar 7, 2026, 15:10Mrunalini Dandamudi: Perspective on Drug Coated Balloons in Coronary In-Stent Restenosis
-
Mar 7, 2026, 15:05Isabelle Mahé: Cancer Site, Bleeding Risk, and Reduced-Dose Apixaban in Cancer-Associated Thrombosis